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background:  The prognostic importance of conventional troponin (cTn) and high-sensitivity troponin (hs-cTn) elevation in patients without 
myocardial infarction (MI) remains unclear. We performed a collaborative meta-analysis comparing the prognosis of patients with MI, 
troponin elevation but no MI (No MI), and troponin negative patients without MI (TN) for both conventional cTn or hs-cTn assays.
methods:  We contacted study authors of studies assessing both conventional and hs-cTn in patients with chest pain to provide death, 
MI, or combined (death or MI) outcomes data for patients based on whether or not they had MI during admission. MI was based on the 
conventional assay and 99th percentile cut-points were used.
Results:  From 8 included studies, there were 5109 patients (881 with MI, 836 FP, and 3392 TN for hs-cTn and 888 MI, 208 FP, and 3965 
TN for conventional cTn). Patients with MI experienced significantly higher rates of death, MI, or their combination at 1 month than non-MI 
patients. However, rates of death, MI, or their combination increased dramatically for non-MI patients at 6 and 12 months, so there was no 
difference between patients with initial admission for MI or no MI (Figure). There were no significant differences in outcomes based on hs-
cTn or conventional cTn assays.
conclusion:  Patients with MI have more adverse short term events but patients without MI but with troponin elevation have a comparable 
prognosis by 1 year.
